Tandem Diabetes Care Announces Upcoming Conference Participation
31 10월 2024 - 5:05AM
Business Wire
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin
delivery and diabetes technology company, today announced that
management will host meetings and present a company update at the
following investor conferences:
- UBS Global Healthcare Conference on Thursday, November 14, 2024
at 11:45am Eastern Time (8:45am Pacific Time),
- Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024
at 11:30am Eastern Time (8:30am Pacific Time),
- Jefferies London Healthcare Conference on Wednesday, November
20, 2024 at 4:30pm GMT (11:30am ET, 8:30am PT), and
- Wolfe Research Healthcare Conference on Wednesday, November 20,
2024 at 8:40am Eastern Time (5:40am Pacific Time).
In addition, the Company will host meetings at the 2024
Canaccord Genuity MedTech, Diagnostics and Digital Health &
Services Forum on Thursday, November 21, 2024.
The presentations will be webcast live, and an archive recording
will be available for 30 days. The link to the live webcasts and
archive will be accessible on Tandem Diabetes Care’s Investor
Center website located at http://investor.tandemdiabetes.com in the
“Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, a global insulin delivery and diabetes
technology company, manufactures and sells advanced automated
insulin delivery systems that reduce the burden of diabetes
management, while creating new possibilities for patients, their
loved ones, and healthcare providers. The Company’s pump portfolio
features the Tandem Mobi system and the t:slim X2 insulin pump,
both of which feature Control-IQ advanced hybrid closed-loop
technology. Tandem Diabetes Care is based in San Diego, California.
For more information, visit tandemdiabetes.com.
Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi
and t:slim X2 are either registered trademarks or trademarks of
Tandem Diabetes Care, Inc. in the United States and/or other
countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241030276890/en/
Media Contact: 858-366-6900 media@tandemdiabetes.com
Investor Contact: 858-366-6900 IR@tandemdiabetes.com
Tandem Diabetes Care (NASDAQ:TNDM)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Tandem Diabetes Care (NASDAQ:TNDM)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025